Results 31 to 40 of about 28,082 (192)
Prevention of postpartum hemorrhage in low-resource settings: current perspectives. [PDF]
, 2013 BackgroundPostpartum hemorrhage (PPH) is the leading cause of maternal death in low-income countries and is the primary cause of approximately one-quarter of global maternal deaths.
Bell, Suzanne +2 more
core +1 more source
Postpartum hemorrhage prevention in Nepal: a program assessment
BMC Pregnancy and Childbirth, 2017 Background In 2009, the Nepal Ministry of Health and Population launched a national program for prevention of postpartum hemorrhage (PPH) during home births that features advance distribution of misoprostol to pregnant women.
Swaraj Pradhan Rajbhandari +7 more
doaj +1 more source
Science-in-brief: Clinical highlights from BEVA Congress 2016 [PDF]
, 2017 No abstract ...
Chauché, C., Kennedy, R.
core +1 more source
Revista Peruana de Investigación Materno Perinatal, 2019 Objetivos: Evaluar las diferencias en el manejo médico del aborto terapéutico usando Mifepristone más Misoprostol comparado con el uso de Misoprostol solo.
Enrique Guevara-Ríos +19 more
doaj +1 more source
Requests for Abortion in Latin America Related to Concern about Zika Virus Exposure [PDF]
, 2016 With the rapid emergence of Zika virus throughout Latin America and its association with microcephaly, requests for access to abortion medications through online telemedicine have increased in countries where access to safe abortion is not universally ...
Aiken, Abigail R.A. +5 more
core +3 more sources
Use of labour induction and risk of cesarean delivery: A systematic review and meta-analysis [PDF]
, 2014 Background: Induction of labour is common, and cesarean delivery is regarded as its major complication. We conducted a systematic review and meta-analysis to investigate whether the risk of cesarean delivery is higher or lower following labour induction ...
Khan, KS +5 more
core +1 more source
Rectal vs. sublingual misoprostol in cesarean section: three‑arm, randomized clinical trial
Caspian Journal of Internal Medicine, 2022 Background: Misoprostol is a myometrial stimulant with uterotonic properties and can be administered rectally, vaginally, or sublingually. Numerous studies have investigated the effect of misoprostol on the prevention and treatment of PPH (postpartum ...
Fatemeh Zahra Bagheri +4 more
doaj
Knowledge and provision of misoprostol among pharmacy workers in Senegal: a cross sectional study. [PDF]
, 2017 BACKGROUND: Making misoprostol widely available for management of postpartum haemorrhage (PPH) and post abortion care (PAC) is essential for reducing maternal mortality.
Burke, Eva +7 more
core +1 more source
Learning with Patient Campaigners About a German Drug Scandal
Berichte zur Wissenschaftsgeschichte, EarlyView.The West German drug Duogynon was internationally marketed as a “hormone pregnancy test” (HPT) between the 1950s and 1980s. In the late 1960s it came under suspicion for inducing miscarriage, spina bifida, and a spectrum of birth defects similar to those caused by the sedative thalidomide.
Jesse Olszynko‐Gryn +3 more
wiley +1 more source
Pharmacokinetics of repeated doses of misoprostol [PDF]
, 2009 BACKGROUNDMisoprostol is widely used in obstetrics and gynaecology for medical abortion, cervical priming and induction of labour. To aid the design of effective and safe regimens, we have investigated the pharmacokinetic parameters after the vaginal or ...
Ho, PC, Lee, SWH, Schweer, H, Tang, OS
core +1 more source